Immunology

  1. Targeting of the NLRP3 Inflammasome for early COVID-19

    1. Carlo Marchetti
    2. Kara Mould
    3. Isak W. Tengesdal
    4. William J Janssen
    5. Charles A. Dinarello

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  2. CD8+ T cell epitope variations suggest a potential antigen presentation deficiency for spike protein of SARS-CoV-2

    1. Congling Qiu
    2. Chanchan Xiao
    3. Zhigang Wang
    4. Xiongfei Chen
    5. Lijuan Gao
    6. Jieping Deng
    7. Jun Su
    8. Huanxing Su
    9. Evandro Fei Fang
    10. Zhang-Jin Zhang
    11. Guodong Zhu
    12. Jikai Zhang
    13. Caojun Xie
    14. Jun Yuan
    15. Oscar Junhong Luo
    16. Pengcheng Wang
    17. Guobing Chen

    Reviewed by ScreenIT

    2 evaluationsAppears in 1 listLatest version Latest activity

  3. Rapid decay of host basal mRNAs during SARS-CoV-2 infection perturbs host antiviral mRNA biogenesis and export

    1. James M. Burke
    2. Laura A. St Clair
    3. Rushika Perera
    4. Roy Parker

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  4. Nucleic acid delivery of immune-focused SARS-CoV-2 nanoparticles drives rapid and potent immunogenicity capable of single-dose protection

    1. Kylie M. Konrath
    2. Kevin Liaw
    3. Yuanhan Wu
    4. Xizhou Zhu
    5. Susanne N. Walker
    6. Ziyang Xu
    7. Katherine Schultheis
    8. Neethu Chokkalingam
    9. Himanshi Chawla
    10. Jianqiu Du
    11. Nicholas J. Tursi
    12. Alan Moore
    13. Jared Adolf-Bryfogle
    14. Mansi Purwar
    15. Emma L. Reuschel
    16. Drew Frase
    17. Matthew Sullivan
    18. Benjamin Fry
    19. Igor Maricic
    20. Viviane M. Andrade
    21. Christel Iffland
    22. Max Crispin
    23. Kate E. Broderick
    24. Laurent M.P.F. Humeau
    25. Ami Patel
    26. Trevor R.F. Smith
    27. Jesper Pallesen
    28. David B. Weiner
    29. Daniel W. Kulp

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  5. Severity of SARS-CoV-2 infection as a function of the interferon landscape across the respiratory tract of COVID-19 patients

    1. Benedetta Sposito
    2. Achille Broggi
    3. Laura Pandolfi
    4. Stefania Crotta
    5. Roberto Ferrarese
    6. Sofia Sisti
    7. Nicola Clementi
    8. Alessandro Ambrosi
    9. Enju Liu
    10. Vanessa Frangipane
    11. Laura Saracino
    12. Laura Marongiu
    13. Fabio A Facchini
    14. Andrea Bottazzi
    15. Tommaso Fossali
    16. Riccardo Colombo
    17. Massimo Clementi
    18. Elena Tagliabue
    19. Antonio E Pontiroli
    20. Federica Meloni
    21. Andreas Wack
    22. Nicasio Mancini
    23. Ivan Zanoni

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  6. A single dose of replication-competent VSV-vectored vaccine expressing SARS-CoV-2 S1 protects against virus replication in a hamster model of severe COVID-19

    1. Delphine C. Malherbe
    2. Drishya Kurup
    3. Christoph Wirblich
    4. Adam J. Ronk
    5. Chad Mire
    6. Natalia Kuzmina
    7. Noor Shaik
    8. Sivakumar Periasamy
    9. Matthew A. Hyde
    10. Julie M. Williams
    11. Pei-Yong Shi
    12. Matthias J. Schnell
    13. Alexander Bukreyev

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  7. SARS-CoV-2 escape from a highly neutralizing COVID-19 convalescent plasma

    1. Emanuele Andreano
    2. Giulia Piccini
    3. Danilo Licastro
    4. Lorenzo Casalino
    5. Nicole V. Johnson
    6. Ida Paciello
    7. Simeone Dal Monego
    8. Elisa Pantano
    9. Noemi Manganaro
    10. Alessandro Manenti
    11. Rachele Manna
    12. Elisa Casa
    13. Inesa Hyseni
    14. Linda Benincasa
    15. Emanuele Montomoli
    16. Rommie E. Amaro
    17. Jason S. McLellan
    18. Rino Rappuoli

    Reviewed by ScreenIT

    2 evaluationsAppears in 1 listLatest version Latest activity

  8. Naive human B cells engage the receptor binding domain of SARS-CoV-2, variants of concern, and related sarbecoviruses

    1. Jared Feldman
    2. Julia Bals
    3. Clara G. Altomare
    4. Kerri St. Denis
    5. Evan C. Lam
    6. Blake M. Hauser
    7. Larance Ronsard
    8. Maya Sangesland
    9. Thalia Bracamonte Moreno
    10. Vintus Okonkwo
    11. Nathania Hartojo
    12. Alejandro B. Balazs
    13. Goran Bajic
    14. Daniel Lingwood
    15. Aaron G. Schmidt

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  9. Lymphopenia-induced T cell proliferation is a hallmark of severe COVID-19

    1. Sarah Adamo
    2. Stéphane Chevrier
    3. Carlo Cervia
    4. Yves Zurbuchen
    5. Miro E. Raeber
    6. Liliane Yang
    7. Sujana Sivapatham
    8. Andrea Jacobs
    9. Esther Bächli
    10. Alain Rudiger
    11. Melina Stüssi-Helbling
    12. Lars C. Huber
    13. Dominik J. Schaer
    14. Bernd Bodenmiller
    15. Onur Boyman
    16. Jakob Nilsson

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  10. INO-4800 DNA vaccine induces neutralizing antibodies and T cell activity against global SARS-CoV-2 variants

    1. Viviane M. Andrade
    2. Aaron Christensen-Quick
    3. Joseph Agnes
    4. Jared Tur
    5. Charles Reed
    6. Richa Kalia
    7. Idania Marrero
    8. Dustin Elwood
    9. Katherine Schultheis
    10. Mansi Purwar
    11. Emma Reuschel
    12. Trevor McMullan
    13. Patrick Pezzoli
    14. Kim Kraynyak
    15. Albert Sylvester
    16. Mammen P. Mammen
    17. Pablo Tebas
    18. J. Joseph Kim
    19. David B. Weiner
    20. Trevor R. F. Smith
    21. Stephanie J. Ramos
    22. Laurent M. Humeau
    23. Jean D. Boyer
    24. Kate E. Broderick

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity
Previous Page 158 of 175 Next